Related references
Note: Only part of the references are listed.Multidimensional Analysis of the Learning Curve for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Surface Malignancies
Shigeki Kusamura et al.
ANNALS OF SURGERY (2012)
Paraneoplastic Thrombocytosis in Ovarian Cancer
Rebecca L. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Receptor tyrosine kinase and downstream signalling analysis in diffuse malignant peritoneal mesothelioma
Federica Perrone et al.
EUROPEAN JOURNAL OF CANCER (2010)
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
Ignace Vergote et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience
Tristan D. Yan et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Surgical Technique of Parietal and Visceral Peritonectomy for Peritoneal Surface Malignancies
Marcello Deraco et al.
JOURNAL OF SURGICAL ONCOLOGY (2009)
Malignant peritoneal mesothelioma-Results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent
G. Carteni et al.
LUNG CANCER (2009)
A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei
A. L. Farquharson et al.
BRITISH JOURNAL OF CANCER (2008)
Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma:: Final report of a phase II trial
George R. Simon et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Morbidity, toxicity, and mortality classification systems in the local regional treatment of peritoneal surface malignancy
Ram Younan et al.
JOURNAL OF SURGICAL ONCOLOGY (2008)
Pseudomyxoma peritonei: Clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)
Dario Baratti et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity
Shigeki Kusamura et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Systemic chemotherapy in the management of malignant peritoneal mesothelioma
R. Garcia-Carbonero et al.
EJSO (2006)
Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma:: Outcomes of an expanded access program
Pasi A. Jaenne et al.
CLINICAL LUNG CANCER (2005)
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma
NJ Vogelzang et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Share Paper
